Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via <scp>cAMP</scp>/<scp>PKA</scp>/<scp>CREB</scp>‐FtMt signalling axis
Shipeng Gong(Nanfang Hospital), Fei Wu(Second Affiliated Hospital of Xi'an Jiaotong University)
Cited by 28
Related Papers
Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer
|Oncotarget|2017|45
Norepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer
|Molecular Oncology|2020|35
MicroRNA-214 targets Wnt3a to suppress liver cancer cell proliferation
|Molecular Medicine Reports|2017|18
Expression of a chimeric human/salmon calcitonin gene integrated into the Saccharomyces cerevisiae genome using rDNA sequences as recombination sites
|Applied Microbiology and Biotechnology|2015|11